LH Pretreatment as a Novel Strategy for Poor Responders

Table 1

Results of the randomized controlled trial: ovarian response.

	Group A	Group B	value
Number of patients	21	22
Age	34.8 ± 3.6	34.3 ± 3.7	n.s.
Number of cancelled cycles (%)	9 (43%)	5 (23%)	n.s
Total IU of rFSH	3906 ± 1367	4152 ± 1429	n.s
Estradiol on HCG day (pg/mL)	651 ± 150	725 ± 150	n.s.
Number of collected oocytes	31 (2.4 ± 1)	58 (3.5 ± 1.7)	<0.05
Number of metaphase II oocytes (%)	27 (87%)	52 (89%)	n.s
Testosterone (ng/mL) at the start of FSH stimulation	0.43 ± 0.23	0.39 ± 0.18	n.s
DHEA (ng/mL) at the start of FSH stimulation	7.2 ± 2.66	7.5 ± 3.54	n.s